PACLX
Price
$36.08
Change
-$0.35 (-0.96%)
Updated
Sep 6 closing price
VLAAX
Price
$44.83
Change
-$0.27 (-0.60%)
Updated
Sep 6 closing price
Ad is loading...

PACLX vs VLAAX

Header iconPACLX vs VLAAX Comparison
Open Charts PACLX vs VLAAXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$36.08
Change-$0.35 (-0.96%)
VolumeN/A
CapitalizationN/A
Value Line Asset Allocation Investor
Price$44.83
Change-$0.27 (-0.60%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PACLX vs VLAAX Comparison Chart
Loading...
VS
PACLX vs. VLAAX commentary
Sep 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a Buy and VLAAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 62.5B vs. VLAAX (948M). PACLX pays higher dividends than VLAAX: PACLX (1.77) vs VLAAX (0.95). PACLX was incepted earlier than VLAAX: PACLX (20 years) vs VLAAX (31 years). PACLX is a more actively managed with annual turnover of: 65.10 vs. VLAAX (29.00). VLAAX has a lower initial minimum investment than PACLX: VLAAX (1000) vs PACLX (2500). PACLX annual gain was more profitable for investors over the last year : 13.12 vs. VLAAX (10.93). PACLX return over 5 years is better than : 23.50 vs. VLAAX (19.91).
PACLXVLAAXPACLX / VLAAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years31 years-
Gain YTD9.10510.75685%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets62.5B948M6,593%
Annual Yield % from dividends1.770.95187%
Returns for 1 year13.1210.93120%
Returns for 3 years-2.17-4.8944%
Returns for 5 years23.5019.91118%
Returns for 10 years47.7967.1371%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYTM48.271.38
+2.94%
Rhythm Pharmaceuticals
CBL25.900.01
+0.04%
CBL & Associates Properties
NTNX62.850.02
+0.03%
Nutanix
MKFG0.23N/A
-0.82%
Markforged Holding Corp
BRTX1.55-0.08
-4.91%
BioRestorative Therapies